Literature DB >> 9743914

Methotrexate loaded chitosan and chitin microspheres--in vitro characterization and pharmacokinetics in mice bearing Ehrlich ascites carcinoma.

U V Singh1, N Udupa.   

Abstract

Methotrexate (MTX) loaded chitosan and chitin microspheres were prepared. The physicochemical characteristics were affected by various parameters, e.g. stirring speed, concentration of chitosan and chitin. The t1/2 for in vitro release varied depending on the concentration of chitosan and chitin and the amount of glutaraldehyde used. The antitumour activity in Ehrlich ascites tumour bearing mice for MTX loaded chitosan microspheres was better when compared with plane MTX on oral administration. The plasma drug levels were sustained.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9743914     DOI: 10.3109/02652049809008242

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  5 in total

1.  Two-stage optimization process for formulation of chitosan microspheres.

Authors:  Rajesh R Dubey; Rajesh H Parikh
Journal:  AAPS PharmSciTech       Date:  2004-02-06       Impact factor: 3.246

2.  Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma.

Authors:  Anna A Alekseeva; Ekaterina V Moiseeva; Natalia R Onishchenko; Ivan A Boldyrev; Alexander S Singin; Andrey P Budko; Zoya S Shprakh; Julian G Molotkovsky; Elena L Vodovozova
Journal:  Int J Nanomedicine       Date:  2017-05-15

3.  Prevention by chitosan of myelotoxicity, gastrointestinal toxicity and immunocompetent organic toxicity induced by 5-fluorouracil without loss of antitumor activity in mice.

Authors:  Y Kimura; H Okuda
Journal:  Jpn J Cancer Res       Date:  1999-07

Review 4.  Polymeric particulates to improve oral bioavailability of peptide drugs.

Authors:  Florence Delie; María José Blanco-Príeto
Journal:  Molecules       Date:  2005-01-31       Impact factor: 4.411

5.  Smart Injectable Chitosan Hydrogels Loaded with 5-Fluorouracil for the Treatment of Breast Cancer.

Authors:  Ahmed A H Abdellatif; Ahmed M Mohammed; Imran Saleem; Mansour Alsharidah; Osamah Al Rugaie; Fatma Ahmed; Shaaban K Osman
Journal:  Pharmaceutics       Date:  2022-03-17       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.